Adamas to Present at Two Upcoming Investor Conferences

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
48
Adamas to Present at Two Upcoming Investor Conferences

EMERYVILLE, Calif., June 01, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that Gregory T. Went, Ph.D., the company’s Chairman and Chief Executive Officer, is scheduled to present at two upcoming investor conferences:

  • Jefferies 2017 Global Healthcare Conference on Tuesday, June 6, 2017 at 9:30 a.m. ET
  • JMP Securities 2017 Life Science Conference on Tuesday, June 20, 2017 at 11:30 a.m. ET

The presentations will be webcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events.cfm . Archived versions of the webcast will be available via replay for 30 days following the presentations.

About Adamas Pharmaceuticals, Inc. Adamas develops new medicines to improve the daily lives of those affected by chronic neurologic disorders, including Parkinson’s disease, multiple sclerosis, epilepsy, and Alzheimer’s disease. Adamas has pioneered a platform to develop medicines for chronic neurologic disorders based on an understanding of the time-dependent biologic processes responsible for disease activity and drug response. The company’s most advanced product candidate, ADS-5102, is a high-dose amantadine, taken once daily at bedtime, in development for the treatment of levodopa-induced dyskinesia in people with Parkinson’s disease and for the treatment of walking impairment in people with multiple sclerosis. A New Drug Application supporting ADS-5102 for the treatment of levodopa-induced dyskinesia in people with Parkinson’s disease is under review by the FDA with a PDUFA date of August 24, 2017. Adamas is exploring other indications for further development of ADS-5102. Adamas is also investigating ADS-4101 for the treatment of partial onset seizures in patients with epilepsy. Additionally, Adamas’ licensed assets, are currently marketed by Allergan under the brand names NAMENDA XR ® and NAMZARIC ® , and Adamas is eligible to receive royalties on sales of these medicines beginning in June 2018 and May 2020, respectively. For more information, please visit www.adamaspharma.com .

NAMENDA XR ® and NAMZARIC ® are trademarks of Merz Pharma GmbH & Co. KGaA.

Contact: Martin Forrest Vice President, Corporate Communications & Investor Relations Adamas Pharmaceuticals, Inc. 510-450-3528 ir@adamaspharma.com Ashleigh Barreto Director, Corporate Communications & Investor Relations Adamas Pharmaceuticals, Inc. 510-450-3567

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LA Auto Show Partners with PetSet: A Charitable Drive

Updated Category News Views 61

A Unique Partnership Between Cars and Compassion Los Angeles is no stranger to the vibrant blend of culture and cars. This year, the Los Angeles Auto Show decided to steer things to a new lane of compassion by teaming up with PetSet. Now, if you're scratching your head wondering how the automobile world rides in tandem with animal welfare, grab a seat. The 'Road to Home...

Continue Reading
The Spice & Tea Exchange® Hits 100 Store Milestone

Updated Category News Views 104

Reaching the Century Mark in Retail Ah, retail. It's a rough-and-tumble world out there, but today we're tipping our hats to The Spice & Tea Exchange® for hitting the 100-store milestone. This brand's fresh out the kitchen with a shiny new store in Eureka Springs, Arkansas, marking a big moment for a franchise that's become a hot commodity in the realm of spices and...

Continue Reading
Horizon Petroleum Expands Leadership for European Growth

Updated Category News Views 98

You don't see leaders with this kind of pedigree lining up every day, especially not in the oil and gas sector. Horizon Petroleum, making a bold move to bolster its leadership with the addition of Mr. John D. Wright as Non-Executive Chairman and Mr. Andrew Judson to the board, is gearing up for what seems like a solid push toward strengthening their European natural gas...

Continue Reading
Poland Bolsters Defense with SATIM SAR Software

Updated Category News Views 67

Poland's Defense Strategy Enters a New Era Scrap what you know about sitting around waiting for intelligence. Poland's Ministry of National Defence has jumped on a new gig with SATIM to revolutionize how they handle satellite radar imagery. This ain't child's play—this deal's all about putting the pedal to the metal with SAR, or synthetic aperture radar, analytics under...

Continue Reading
HLTH 2026: AI's Role in Couples Therapy Unveiled

Updated Category News Views 28

Testing AI's Place in the Therapy Room AI's getting more action in therapy sessions than it ever dreamed, and it’s high time we asked who benefits and who loses. Slotting in next to human therapists, AI like OurRitual’s Ora isn't about to steal the whole show, but it sure knows how to play a supporting role. At the HLTH 2026 conference, Dr. Orna Guralnik and OurRitual...

Continue Reading
Vipshop Sets 2026 AGM: Shareholders Meet on Dec 8

Updated Category News Views 21

Blockbuster or Bust: Vipshop's Upcoming AGM Here's the scoop: Vipshop Holdings Limited, with its mammoth operations in China's off-price retail sector, is gearing up for its annual general meeting (AGM) on December 8, 2026. This is where management and stakeholders will hash out everything from strategic pivots to financial health. Forget shareholder votes this...

Continue Reading
Health In Tech's Rocky Q3: Navigating Losses and Opportunities

Updated Category News Views 35

Signs of Optimism Amidst Financial Struggles Health In Tech is wading through the choppy waters of its Q3 2026 financial results—revenue came in at $6.6 million, down from $8.5 million the previous year. Seems like their investments are all geared up, but the sails aren’t quite catching wind yet. That said, their contracted revenue strutted to $32.7 million for the...

Continue Reading
Wastewater Treatment Market to Hit $99.56B by 2031

Updated Category News Views 141

The Changing Face of Wastewater Treatment Here's a whopper to chew on: the wastewater treatment services market ain't your grandfather's playground anymore. No sir, it's a fast-evolving arena aiming to swell to a whopping USD 99.56 billion by 2031. Now, how's that for growth? Mark my words, driven by stringent environmental regulations and thirst for clean water, this...

Continue Reading
Kargo's Tech Boosts Profit on Seafood Supply Chain

Updated Category News Views 78

Revolutionizing Seafood Logistics with Kargo You'd think managing seafood shipments would be a simpler gig than charting ocean routes, but think again. Northern Wind, a major player in seafood processing, just proved the power of tech in an old-school business by partnering with a slick AI outfit called Kargo. Their facility in New Bedford, Massachusetts now magically...

Continue Reading
Exus Bags $345M Financing for U.S. Energy Growth

Updated Category News Views 70

Something's Stirring in the Renewables Sector You ever feel like the renewable energy world is moving at a breakneck pace? Well, hold onto your hat because Exus Renewables North America just secured a hefty $345 million in financing led by Goldman Sachs Alternatives. It's got "big developments" written all over it, folks. What's the Deal Here? The funds are aimed squarely...

Continue Reading
"btn" href="https://investorshangout.com/blog/news?page=2">More News Articles